DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 Company Registration Number: NI070807 Charity Registration Number: 101272 Charis Cancer Care Ltd (Charitable Company Limited by Guarantee) Annual Report and Audited Financial Statements For the year ended 31 October 2023 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd (Charitable Company Limited by Guarantee) ## CONTENTS For the year ended 31 October 2023 ||Page| |---|---| |`General Information`|`2`| |`Directors’ Report`|`3 – 5`| |`Independent Auditor’s Report`|`6 – 9`| |`Consolidated Statement of Financial Activities`|`10`| |`Consolidated Statement of Financial Position`|`11`| |`Company Statement of Financial Position`|`12`| |`Consolidated Statement of Cash Flows`|`13`| |`Notes to the Financial Statements`|`14 – 28`| CavanaghKelly, Chartered Accountants & Statutory Auditors `Page 1` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## GENERAL INFORMATION Board of Directors `Jarlath Conway` (resigned 7 November 2023) `Steven McKay Dr Ben Glancy Thomas Diamond Kirsty McManus David Henry Peter Stafford Professor Marie Louise McHugh Roisin Toner` Registered Office `163 Lough Fea Road Ballybreist Cookstown Co. Tyrone BT80 9TU` Company Registration Number `NI070807` Charity Registration Number `101272` Independent Auditors `CavanaghKelly Chartered Accountants and Statutory Auditors 36 - 38 Northland Row Dungannon Co. Tyrone BT71 6AP` Solicitors `P.A. Duffy & Co 27-29 Broad St Magherafelt Co. Londonderry BT45 6EB` Bankers `Bank of Ireland Market Street Magherafelt Co. Londonderry BT45 6EE` **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors `Page 2` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## DIRECTORS’ REPORT for the year ended 31 October 2023 ``` The Directors, who are the trustees for the purpose of charity law, have pleasure in presenting their report and the audited financial statements of the charitable company for the year ended 31 October 2023. ``` ``` The financial statements have been prepared in accordance with the Statement of Recommended Practice “Accounting and Reporting by Charities” (FRS 102), United Kingdom Generally Accepted Accounting Practice and the Companies Act 2006. ``` ## Reference and Administration Details ``` The reference and administration details of the charitable company are as shown on page 2. ``` ``` The Chief Executive was responsible for the supervision of the day-to-day operations of the charitable company throughout the year. ``` ## Objectives and Activities ``` The main function of the charity is to provide complimentary cancer treatments to the people of Northern Ireland. These services are provided free and include families of people affected by cancer. ``` ``` Charis Cancer Care Ltd works in conjunction with clinical treatments for cancer and our comfortable treatment rooms are purpose-designed for the delivery of complementary therapies by trained practitioners free of charge. Individual and group therapies are available. Treatments provided to Cancer Care Patients include massage, relaxation aromatherapy, reflexology, yoga, financial planning and dietary support. ``` ## Public Benefit Statement ``` The Directors of Charis Cancer Care Ltd confirm that they have complied with their duty under section 4(6) of the Charities Act (Northern Ireland) 2008 to have regard to the Charity Commission for Northern Ireland’s guidance on public benefit and that the public benefit requirement has informed the activities of the charitable company in the year ended 31 October 2023. ``` ## Achievements and Performance ``` The Board of Directors are confident the charity continues to meet its performance objectives and continues to receive excellent feedback from clients. The centre provides a high-quality service to clients from all over Northern Ireland. During the year ended 31 October 2023, 1,256 new clients availed of the services provided by the Charity, bringing the total number of clients assisted to date to 12,018. ``` ## Financial Review ## Financial Performance ``` The financial performance was in line with Directors’ expectations. The charitable group remains in a sound financial position at the year end. The results for the year are set out in details on pages 9 to 27. The group had net incoming resources for the year of £52,400 (2022 – £83,072 of outgoing resources). ``` ``` At 31 October 2023, the total funds of the group amounted to £1,254,115 (2022: £1,201,715). The total charity funds amounted to £1,154,993 (2022 - £1,148,353) Principal sources of funding and how this has supported the key objectives of the charity are disclosed in the notes to the financial statements. ``` **__________________________________________________________________________________________** ## CavanaghKelly, Chartered Accountants & Statutory Auditors ``` Page 3 ``` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## DIRECTORS’ REPORT for the year ended 31 October 2023 (Continued) ## Financial Review (Continued) ## Reserves Policy ``` In the prior year, the Board of Directors implemented two additional funds to the charity’s unrestricted funds to help control and monitor everyday running costs as well as for future capital projects. This seen the implementation of a Capital Fund and a Designated Fund as noted below. ``` ## Unrestricted Funds: – Capital Funds `Funds earmarked for future capital projects to assist with the expansion of the charity. Such capital projects are currently being researched by the Board of Directors.` Designated Funds – `Monies which have been set aside to cover costs should there be a significant and unforeseen reduction in funding.` General Funds `– Funds which are expendable at the discretion of the Directors in furtherance of the objectives of the charity.` Restricted Funds `– Income received for specific purposes. Such purposes are within the overall aims of the charity.` ## Structure, Governance and Management ## Organisational Structure ``` The charitable company is a company limited by guarantee, not having a share capital. ``` ``` The charitable company was established under a Memorandum of Association which established the objects and powers of the charitable company and is governed under its Articles of Association. ``` ``` In accordance with the Articles of Association, the members to retire by rotation shall be those who have been longest in office since their last election, and the relevant motion will be put at the Annual General Meeting. A retiring member shall be eligible for re-election. ``` ``` The charitable company is governed by the Board of Trustees. None of the Trustees have any beneficial interest in the charitable company. Any person wishing to become a director must apply in writing prior to the annual general meeting. A vote is then taken at the annual general meeting as to whether that person is appointed. ``` ## Directors ``` The Directors during the year are the same as the Directors as listed on page 2. ``` ## Taxation Status ``` The charitable company is recognised as a charity by HM Revenue & Customs. Accordingly, the charitable company has availed of the exemptions contained in Chapter 3 Part 11 Corporation Taxes Act 2010 and Section 256 Taxation of Chargeable Gains Act 1992. ``` **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors ``` Page 4 ``` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## DIRECTORS’ REPORT for the year ended 31 October 2022 (Continued) ## Directors' Responsibilities ``` The Directors are responsible for preparing the Directors’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). ``` ``` Company law requires the Directors to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to: ``` - `select suitable accounting policies and apply them consistently;` - `observe the methods and principles in the Charities SORP (FRS102);` - `make judgements and estimates that are reasonable and prudent;` - `state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and` - `prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.` ``` The Directors are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. ``` ## Statement of Disclosure of Information to Auditor ``` In so far as the Directors, who held office at the date of approval of these financial statements, are aware: ``` - `there is no relevant audit information of which the charitable company’s auditor is unaware; and` - `the Directors have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.` ## Small Companies Exemption ``` This report is prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006. ``` ``` This report was approved by the Board of Directors on 25 March 2024 and signed on its behalf by: ``` ## Registered office: |Registered office:||| |---|---|---| |`163 Lough Fea Road`||| |`Ballybreist`|`_________________`|`_________________`| |`Cookstown`|Professor Marie Louise McHugh|David Henry| |`BT80 9TU`|Director|Director| Company Registration Number: NI070807 Charity Registration Number: 101272 **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors `Page 5` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023 ## Opinion ``` We have audited the financial statements of Charis Cancer Care Ltd ('the charitable company') for the year ended 31 October 2023 which comprise the Statement of Financial Activities, the Statement of Financial Position, the Statement of Cash Flows and the related notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice). ``` ``` This report is made solely to the charitable company’s Directors, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s Directors those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s Directors as a body, for our audit work, for this report, or for the opinions we have formed. ``` ``` In our opinion the financial statements: ``` - `give a true and fair view of the state of the charitable company's affairs as at 31 October 2023 and of its total incoming resources and expenditure of resources, including its income and expenditure, for the year then ended;` - `have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and` - `have been prepared in accordance with the requirements of the Companies Act 2006.` ## Basis for opinion ``` We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. ``` ## Conclusions relating to going concern ``` We have nothing to report in respect of the following matters in relation to which ISAs (UK) require us to report to you where: ``` - `the directors' use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or` - `the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the charitable company's ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.` **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors `Page 6` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023 (Continued) ## Other information ``` The directors are responsible for the other information. The other information comprises the information included in the Directors’ Report, other than the financial statements and our Auditor's Report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. ``` ``` In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements, or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. ``` ## Opinions on other matters prescribed by the Companies Act 2006 ``` In our opinion, based on the work undertaken in the course of the audit: ``` - `the information given in the Directors’ Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and` - `the Directors’ Report has been prepared in accordance with applicable legal requirements.` ## Matters on which we are required to report by exception ``` In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors’ Report. ``` ``` We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: ``` - `adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or` - `the financial statements are not in agreement with the accounting records and returns; or` - `certain disclosures of directors’ remuneration specified by law are not made; or` - `we have not received all the information and explanations we require for our audit; or` - `the directors were not entitled to prepare the financial statements in accordance with the small companies’ regime and take advantage of the small companies’ exemption in preparing the Directors’ Report.` ## Responsibilities of Directors ``` As explained more fully in the Directors’ Responsibilities Statement, the directors (who are also the trustees of the charitable company for the purpose of charity law), are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. ``` **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors ``` Page 7 ``` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023 (Continued) ## Responsibilities of Directors (Continued) ``` In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intends to liquidate the charitable company or to cease operations, or has no realistic alternative but to do so. ``` ## Auditor’s responsibilities for the audit of the financial statements ``` Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. ``` ``` The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: ``` ``` Irregularities, including fraud, are instances of non-compliance with laws and regulations. The objectives of our audit in respect of fraud are to assess the risk of material misstatement due to fraud, design and implement appropriate responses to those assessed risks and to respond appropriately to instances of fraud or suspected fraud identified during the course of our audit. However, the primary responsibility for the prevention and detection of fraud rests with management and those charged with governance of the charity. ``` ``` In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following: ``` - `We obtained understanding of the legal and regulatory requirements applicable to the company’s financial statements and considered the most significant are the Companies Act 2006, Financial Reporting Standards (FRS102) and Charity SORP;` - `We have assessed the risk of material misstatement of the financial statements, including risk of material misstatement due to fraud and how it might occur by holding discussions with management and those charged with governance;` - `We enquired of management and those charged with governance as to any known instances of non-compliance or suspected non-compliance with laws and regulations;` - `Understanding the internal controls established to mitigate risks related to fraud or noncompliance with laws and regulations; and` - `Discussions amongst the audit engagement team regarding how fraud might occur in the financial statements and any potential indicators of fraud. As part of this discussion, we identified the following potential areas where fraud may occur: timing of revenue recognition and management override.` ``` The audit response to risks identified included: ``` - `Reviewing the financial statements disclosures and testing to supporting documentation to assess compliance with the relevant laws and regulations above;` - `Performing analytical procedures to identify any unusual or unexpected relationships that may indicate risk of material misstatement due to fraud;` **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors `Page 8` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023 (Continued) - `In addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments, assessing whether the judgements made in making accounting estimates are reasonable and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.` ``` In addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments, assessing whether the judgements made in making accounting estimates are reasonable and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business. ``` ``` A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report. ``` ## Use of our Report ``` This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. ``` ``` _______________________________ ``` ## Mr. Ryan Falls FCA (Senior Statutory Auditor) For and on behalf of ## CAVANAGHKELLY ``` Chartered Accountants and Statutory Auditors 36 – 38 Northland Row Dungannon Co. Tyrone BT71 6AP ``` ## Date: 25 March 2024 **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors `Page 9` DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (Including an income & expenditure account) For the year ended 31 October 2023 |ncung an ncome expenture ac
or the year ended 31 October 2023|count)| |---|---| |Income and Endowments
`Donations and legacies (Note 3)`
`Other trading income (Note 3)`
`Investment Income`
`Grant Income`
Income from Other Trading
Activities
`Commercial Trading Operations (Note 4)`
Total Income and Endowments
Resources Expended
`Charitable Activities (Note 5)`
`Commercial Trading Operations (Note 4)`
Total Resources Expended
`Tax charge on Commercial Trading`
`Operations (Note 8)`
Net incoming/(outgoing) resources
for the year
`Balance brought forward`
`Transfer between funds`
Balance carried forward|Unrestricted Funds
Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
`Total Funds`
2023
2023
2023
2023
2023
`2022`
£
£
£
£
£
`£`
`-`
`-`
`224,289`
`-`
224,289
`219,454`
`-`
`-`
`585`
`-`
585
`333`
`-`
`-`
`11,932`
`-`
11,932
`3`
`-`
`-`
`-`
`305,998`
305,998
`151,683`
`-`
`-`
`203,075`
`-`
203,075
`176,636`| ||`-`
`-`
`439,881`
`305,998`
745,879
`548,109`| ||`-`
`-`
`(310,775)`
`(225,390)`
(536,165)
`(452,334)`
`-`
`-`
`(157,314)`
`-`
(157,314)
`(178,847)`| ||`-`
`-`
`(468,089)`
`(225,390)`
(693,479)
`(631,181)`| ||`-`
`-`
`-`
`-`
`-`
`-`| ||`-`
`-`
`(28,208)`
`80,608`
52,400
`(83,072)`
`-`
`250,000`
`762,428`
`189,287`
1,201,715
`1,284,787`
`-`
`-`
`-`
`-`
`-`
`-`| ||`-`
`250,000`
`734,220`
`269,895`
1,254,115
`1,201,715`| ``` The above Statement of Financial Activities includes all information as required to be disclosed by the Companies Act 2006. ``` ``` All of the activities of the charitable company are classed as continuing. The Statement of Financial Activities includes all gains and losses recognised during the year. The notes on pages 14 to 28 form an integral part of the financial statements. ``` **_________________________________________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 10 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## CONSOLIDATED STATEMENT OF FINANCIAL POSITION as at 31 October 2023 |Note
Fixed Assets
Property, Plant and Equipment
8
Investments
9
Current Assets
Receivables
10
Cash and Cash Equivalents
Payables: amounts falling due within
one year
11
Net Current Assets
Net Assets
Represented by:
Unrestricted Funds:
Capital Funds
13
Designated Funds
13
General Funds
13
Restricted Funds
13
Total Funds|2023
2022
£
£
437,546
450,273
-
-| |---|---| ||437,546
450,273
15,976
18,385
819,179
763,063| ||835,155
781,448
(18,586)
(30,006)
816,569
751,442| ||| ||1,254,115
1,201,715| ||-
-
250,000
250,000
734,220
762,428
269,895
189,287| ||1,254,115
1,201,715| These financial statements have been prepared in accordance with the provisions applicable to small companies’ regime within Part 15 of the Companies Act 2006. The notes on pages 14 to 28 form an integral part of the financial statements. These financial statements were approved and authorised for issue by the Board of Directors on 25 March 2024 and signed on their behalf by: _______________________________ _______________________________ Professor Marie Louise McHugh David Henry Director Director Company Registration Number: NI070807 Charity Registration Number: 101272 **_______________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 11 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## COMPANY STATEMENT OF FINANCIAL POSITION as at 31 October 2023 |Note
Fixed Assets
Property, Plant and Equipment
8
Investments
9
Current Assets
Receivables
10
Cash and Cash Equivalents
Payables: amounts falling due within
one year
11
Net Current Assets
Net Assets
Represented by:
Unrestricted Funds:
Capital Funds
13
Designated Funds
13
General Funds
13
Restricted Funds
13
Total Funds
13|2023
2022
£
£
433,900
442,849
1
1| |---|---| ||433,901
442,850
12,529
101,274
722,604
631,489| ||735,133
732,763
(14,041)
(27,260)
721,092
705,503| ||| ||1,154,993
1,148,353| ||£
£
-
-
250,000
250,000
635,098
709,066
269,895
189,287| ||1,154,993
1,148,353| These financial statements have been prepared in accordance with the provisions applicable to small companies’ regime within Part 15 of the Companies Act 2006. The notes on pages 14 to 28 form an integral part of the financial statements. These financial statements were approved and authorised for issue by the Board of Directors on 25 March 2024 and signed on their behalf by: _______________________________ _______________________________ Professor Marie Louise McHugh David Henry Director Director Company Registration Number: NI070807 Charity Registration Number: 101272 **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 12 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## CONSOLIDATED STATEMENT OF CASH FLOWS ## For the year ended 31 October 2023 |Charis Cancer Care Ltd
(Charitable Company Limited by Guarantee)
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended 31 October 2023|| |---|---| |Cash flows from operating activities
Surplus/(Deficit) for the year
Adjustments for:
Depreciation
Amortisation of government grants
Profit on disposal of freehold property
Movements in working capital:
Movement in receivables
Movement in payables
Net cash generated from operating activities
Cash flows from investing activities
Payments to acquire property, plant and equipment
Receipts from disposals of property, plant and equipment
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of financial year
Cash and cash equivalents at end of financial year
Cash and cash equivalents consist of:
Cash at bank and in hand|2023
2022
£
£
52,400
(83,072)
21,327
21,577
-
-
-
-| ||73,727
(61,495)
2,409
(2,309)
(11,420)
(102,770)| ||(9,011)
(105,079)| ||64,716
(166,574)| ||(8,600)
(13,507)
-
-| ||56,116
(180,081)
763,063
943,144| ||819,179
763,063| ||2023
2022
£
£
819,179
763,063| **_______________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 13 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS For the year ended 31 October 2023 ## 1. GENERAL INFORMATION Charis Cancer Care Ltd is a charitable company limited by guarantee incorporated in Northern Ireland. In the event of the charitable company being wound up, the liability in respect of the guarantee is limited to £1 per member of the charitable company. The address of the registered office is as shown on page 2. The charitable company constitutes a public benefit entity as defined by FRS 102. ## 2. ACCOUNTING POLICIES The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the charitable company’s financial statements. ## 2.1 Statement of Compliance The financial statements have been prepared in accordance with Accounting and Reporting by Charites: Statement of Recommended Practice (SORP) applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) effective 1 January 2019 (Second Edition), the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Companies Act 2006. ## 2.2 Basis of Preparation The financial statements are prepared on a going concern basis under the historical cost convention unless otherwise stated in the relevant accounting policy. Historical cost is generally based on the fair value of the consideration given in exchange for assets. The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the charitable company's financial statements. ## 2.3 Group Financial Statements The financial statements consolidate the results of the charity and its subsidiary, Friends of Charis Limited. ## 2.4 Income and Endowments ## (i) Donations and Legacies Donations and Legacy income includes gifts, donations and grants and is recognised in full in the Statement of Financial Activities when evidence to entitlement is obtained. **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 14 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023 ## 2. ACCOUNTING POLICIES (Continued) ## 2.4 Income and Endowments (Continued) (ii) Other Trading Income Activities for generating funds are commercial activities which are recognised as earned when the related goods and services are provided. ## (iii) Commercial Trading Income Trading income represents the invoiced value of goods supplied during the year excluding value added tax. Revenue is recognised upon provision of the service to the customer. ## 2.5 Resources Expended Expenditure is recognised when a liability is incurred. Contractual arrangements and performance related grants are recognised as goods and services are supplied. Where costs cannot be directly attributed to a particular heading they have been allocated to activities on a basis consistent with use of resources. Staff costs and overhead expenses are allocated to activities on the basis of staff time spent on those activities. ## (i) Charitable Activities This compromises all the resources applied by the charity in undertaking its work to meet its charitable objectives. Charitable activities will include the costs of governance arrangements which relate to the general running of the charity. ## 2.6 Fund Accounting The charity has four types of funds for which it is responsible at the year-end: Capital Funds – Funds earmarked for future capital projects to assist with the expansion of the charity. Such capital projects are currently being researched by the Board of Directors. Designated Funds - Funds held in reserve to cover any future reductions in funding and allow the charity to continue to meet its obligations to staff and creditors. Unrestricted Funds – Funds which are expendable at the discretion of the Directors in furtherance of the objectives of the charity. Restricted Funds – Income received for specific purposes. Such purposes are within the overall aims of the charity. **_______________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 15 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023 ## 2. ACCOUNTING POLICIES (Continued) ## 2.7 Property, Plant and Equipment and Depreciation All property, plant and equipment are initially recorded at cost. Cost includes the original purchase price, costs directly attributable to bringing the asset to its working condition for its intended use, dismantling and restoration costs and borrowing costs capitalised. Depreciation is provided at rates calculated to write off the cost less residual value of each asset over its expected useful life, as follows: |Land and Buildings|2%|Straight line| |---|---|---| |Office Equipment|20%|Straight line| |IT Equipment|25%|Straight line| |Fixtures and Fittings|20%|Straight line| |Motor Vehicles|20%|Straight line| ## 2.8 Cash and Cash Equivalents Cash and cash equivalents includes cash in hand, deposits held at call with banks, other shortterm highly liquid investments with original maturities of three months or less. ## 2.9 Investments Investments in subsidiaries are valued at cost less provision for impairment. Income from investments together with any related tax credit is recognised in the statement of financial activities in the year in which it is receivable. ## 2.10 Trade and Other Receivables Trade and other receivables are initially recorded at fair value and thereafter stated at cost less impairment losses for bad and doubtful debts. ## 2.11 Trade and Other Payables Trade and other payables are initially recognised at fair value and thereafter stated at cost. ## 2.12 Taxation As a charity, the charitable company is not liable to Corporation Tax. The trading subsidiary is however liable to corporation tax. Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date. **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 16 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023 Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. ## 2.13 Critical accounting estimates and judgements In the application of the Charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. Critical judgements in applying the entity’s accounting policies There are no critical judgements in applying the group’s accounting policies. Critical accounting estimates and assumptions There are no accounting estimates in applying the group’s accounting policies. ## 2.14 Pension and other post retirement obligations The charity operates a defined contribution pension scheme which is a pension plan under which fixed contributions are paid into a pension fund and the charity has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current or prior periods. Contributions to defined contribution plans are recognised in the Statement of Financial Activities when they are due. If contribution payments exceed the contribution due for the service, the excess is recognised as a prepayment. ## 2.15 Financial Instruments ## (i) Financial assets Basic financial assets, including trade and other receivables, cash and bank balances and amounts owed by related parties and are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method. **_______________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 17 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023 At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss. If there is decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss. Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions. ## (ii) Financial liabilities Basic financial liabilities, including trade and other payables, bank loans and overdrafts and amounts owed to related parties are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Fees paid on the establishment of loan facilities are recognised as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. To the extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalised as a pre-payment for liquidity services and amortised over the period of the facility to which it relates. Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires. ## (iii) Offsetting Financial assets and liabilities are offset, and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. **_______________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 18 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) ## For the year ended 31 October 2023 ## 2.16 Exemptions under FRS 102 The charity has taken advantage of the following exemption: (i) From preparing a cash flow statement, on the basis that it is a qualifying entity, and the consolidated statement of cash flow includes the charity’s cash flows. ## 2.17 Exemptions under Companies Act 2006 The charity has taken advantage of the following exemption: - (i) From preparing a Statement of Financial Activities on the basis that the Consolidated Statement of financial activities includes the charity's statement. **_______________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 19 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023 ## 3. INCOME AND ENDOWMENTS ## Unrestricted Funds |
or the year ended 31 October
. INCOME AND ENDOWMENTS|(onnue)
2023
Unrestricted Funds| |---|---| |Donations and Endowments
`Client Donations`
`Fundraising – voluntary income`
`HMRC Gift Aid`
Total Donations and
Endowments|Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
`Total Funds`
2023
2023
2023
2023
2023
`2022`
£
£
£
£
£
`£`
`-`
`-`
`178,684`
`-`
178,684
`180,577`
`-`
`-`
`45,605`
`-`
45,605
`33,872`
`-`
`-`
`-`
`-`
-
`5,005`| ||`-`
`-`
`224,289`
`-`
224,289
`219,454`| ``` Income from donations and endowments in the year ended 31 October 2022 of £219,454 was made up entirely of monies from unrestricted income. ``` ## Unrestricted Funds ||Unrestricted Funds| |---|---| |Other Trading Activities
`Books, pens and CDs`
`Mentoring income`
Total Income from Other
Trading Activities|Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
`Total Funds`
2023
2023
2023
2023
2023
`2022`
£
£
£
£
£
`£`
`-`
`-`
`351`
`-`
351
`333`
`-`
`-`
`234`
`-`
234
`-`| ||`-`
`-`
`585`
`-`
585
`333`| ``` Income from other trading activities in the year ended 31 October 2022 of £333 was made up entirely of monies from unrestricted income. ``` **_________________________________________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 20 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd (Charitable Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023 ## 3. INCOME AND ENDOWMENTS ## Unrestricted Funds |. INCOME AND ENDOWMENTS|Unrestricted Funds| |---|---| |Investment Income
`Bank Interest Receivable`
Total Investment Income|Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
`Total Funds`
2023
2023
2023
2023
2023
`2022`
£
£
£
£
£
`£`
`-`
`-`
`11,932`
`-`
11,932
`3`| ||`-`
`-`
`11,932`
`-`
11,932
`3`| ``` Income investment income in the year ended 31 October 2022 of £3 was made up entirely of monies from unrestricted income. ``` ## 3. INCOME AND ENDOWMENTS ## Unrestricted Funds |. INCOME AND ENDOWMENTS|Unrestricted Funds| |---|---| |Grant Income
`Department of Health – Community`
`Foundation`
`Other grants received in the year`
Total Grant Income|Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
`Total Funds`
2023
2023
2023
2023
2023
`2022`
£
£
£
£
£
`£`
`-`
`305,998`
305,998
`104,383`
`-`
`-`
`-`
`-`
`-`
`47,300`| ||`-`
`-`
`-`
`305,998`
305,998
`151,683`| ``` Grant income received in the year ended 31 October 2022 amounting to £151,683 was made up of £1,000 general funds and £150,683 restricted funds. ``` **_________________________________________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 21 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023 ## 4. INCOME FROM OTHER TRADING ACTIVITIES The trading subsidiary of the charity is Friends of Charis Limited. The company is incorporated in Northern Ireland within the United Kingdom (company number NI605705). ## Registered Address of Subsidiary: 163 Lough Fea Road Ballybreist Cookstown Co. Tyrone BT80 9TU ## Friends of Charis Limited |Friends of Charis Limited|| |---|---| |Turnover
Cost of Sales
Administrative Expenses
Donation to Charis Cancer Care
Other Income
Tax on profit/(loss)
Net Profit/(loss)
Aggregate Share Capital and Reserves|2023
2022
£
£
203,075
176,336
(92,089)(103,998)
(65,225)
(74,849)
-
-
-
300
-
-| ||45,761
(2,211)| ||99,123
53,362| Included within Friends of Charis Ltd financials above is a donation to Charis Cancer Care Limited of £nil (2022: £nil). This donation is accounted for as income in the parent company but is removed within the Statement of Financial Activities on consolidation under the SORP requirements. **_________________________________________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 22 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd (Charitable Company Limited by Guarantee) ## 5. RESOURCES EXPENDED ## Unrestricted Funds |. RESOURCES EXPENDED|Unrestricted Funds| |---|---| |Charitable Activities
Therapists
Wages and salaries (incl pension
contributions)
Fundraising costs
Insurance
Heat and light
Motor expenses
Advertising
Repairs and maintenance
Cleaning
Computer costs
Staff training
Subscriptions
Telephone and internet
Printing, postage and stationery
Audit and accountancy
Legal and professional fees
Consultancy
General expenses
Bank charges
Depreciation
Total Resources Expended|Capital
Funds
Designated
Funds
General Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
-
90,615
140,677
231,292
189,446
-
-
120,953
69,865
190,818
163,854
-
-
3,009
-
3,009
2,236
-
-
5,047
-
5,047
4,567
-
-
9,814
1,753
11,567
7,592
-
-
2,019
-
2,019
1,028
-
-
1,298
-
1,298
828
-
-
3,203
3,992
7,195
4,921
-
-
6,266
-
6,266
4,345
-
-
9,285
-
9,285
13,770
-
-
1,189
2,250
3,439
750
-
-
466
-
466
288
-
-
5,342
-
5,342
5,380
-
-
6,506
3,177
9,683
8,202
-
-
7,441
-
7,441
8,294
-
-
21,808
-
21,808
1,410
-
-
-
-
-
3,238
-
-
2,278
76
2,354
14,084
-
-
287
-
287
302
-
-
13,949
3,600
17,549
17,799| ||-
-
310,775
225,390
536,165
452,334| Expenditure on charitable activities in the year ended 31 October 2022 of £452,334 is made up of £301,651 of unrestricted expenditure and £150,683 of restricted expenditure. **_________________________________________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 23 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023 ## 6. NET INCOME/(EXPENDITURE) FOR THE YEAR Net income/(expenditure) is stated after charging/(crediting): |6. NET INCOME/(EXPENDITURE) FOR THE YEAR
Net income/(expenditure) is stated after charging/(crediting):|| |---|---| |Depreciation
Auditor’s remuneration
7. AUDITORS' REMUNERATION
Auditor’s remuneration
– audit services|2023
2022
£
£
17,549
17,779
7,441
8,294| ||24,990
26,073| ||2023
2022
£
£
7,441
8,294| ||7,441
8,294| ## 8. STAFF COSTS AND EMPLOYEE BENEFIT The average number of persons employed by the charitable company during the year was 7 (2022: 6). The total staff costs and employee benefits were as follows: |e average numer o persons empoye y te cartae compa
6).
The total staff costs and employee benefits were as follows:|ny urng te year was (:| |---|---| |Gross wages and salaries
Employers national insurance contributions and pension
contributions|2023
2022
£
£
179,001
152,880
11,817
10,974| ||190,818
163,854| No employee of the charitable company received total employee benefits of more than £60,000. ## 8.1. DIRECTORS’ REMUNERATION The Directors received nor waived any remuneration or any other benefits during the year and no reimbursements of expenses incurred. **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 24 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023 ## 9. PROPERTY, PLANT AND EQUIPMENT |GROUP
Cost
`At 31 October 2022`
`Additions`
`At 31 October 2023`
Depreciation
`At 31 October 2022`
`Charge for year`
`At 31 October 2023`
Carrying amount
At 31 October 2023
`At 31 October 2022`
CHARITY
Cost
`At 31 October 2022`
`Additions`
`At 31 October 2023`
Depreciation
`At 31 October 2022`
`Charge for year`
`At 31 October 2023`
Carrying amount
At 31 October 2023
`At 31 October 2022`|Land and
buildings
£
Office
Equipment
£
IT
Equipment
£
Fixtures and
fittings
£
Motor
Vehicles
£
Total
£
`434,545`
`6,762`
`46,805`
`128,530`
`36,545`
653,187
`-`
`414`
`8,186`
`-`
`-`
8,600
`434,545`
`7,176`
`54,991`
`128,530`
`36,545`
661,787
`18,423`
`6,762`
`29,389`
`118,407`
`29,933`
202,914
`7,261`
`30`
`6,868`
`3,718`
`3,450`
21,327
`25,684`
`6,792`
`36,257`
`122,125`
`33,383`
224,241
408,861
384
18,734
6,405
3,162
437,546
`416,122`
`-`
`17,416`
`10,123`
`6,612`
`450,273`
`434,545`
`6,762`
`42,415`
`97,504`
`22,745`
`603,971`
`-`
`414`
`8,186`
`-`
`-`
`8,600`| |---|---| ||`434,545`
`7,176`
`50,601`
`97,504`
`22,745`
`612,571`| ||`18,423`
`6,762`
`24,999`
`88,193`
`22,745`
`161,122`
`7,261`
`30`
`6,868`
`3,390`
`-`
`17,549`| ||`25,684`
`6,792`
`31,867`
`91,583`
`22,745`
`178,671`| ||| ||408,861
384
18,734
5,921
-
433,900| ||`416,122`
`-`
`17,416`
`9,311`
`-`
`442,849`| **__________________________________________________________________________________________** CavanaghKelly, Chartered Accountants & Statutory Auditors Page 25 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023 ## 10. INVESTMENTS |10. INVESTMENTS|||| |---|---|---|---| ||||Subsidiary| ||||Undertaking| ||||Shares| ||||£| |Cost|||| |At 31 October 2022 and 31 October 2023|||1| |Carrying amount|||| |At 31 October 2023|||1| |At 31 October 2022|||1| |10.1 Holdings in subsidiary undertakings|||| |Name|Company|Details of|Proportion held| ||Registration|Investment|by Charity| ||Number||| |Friends of Charis Limited|NI605705|Ordinary|100%| The aggregate amount of capital and reserves and the results of these undertakings for the last relevant financial year were as follows: |Name|Year Ended|
Capital and|
Capital and|Profit/(loss)|Profit/(loss)| |---|---|---|---|---|---| |||Reserves (£)||(£)|| |Friends of Charis Limited|31 October 2023||99,123||45,761| |11. RECEIVABLES|||||| |||Group||Charity|| |||2023|2022|2023|2022| |||£|£|£|£| |Trade receivables||234|-|234|-| |Other debtors||3,856|5,005|3,856|5,005| |Amounts owed by group company||-|-|-|85,846| |Prepayments and accrued income||9,482|11,466|8,439|10,423| |VAT||2,404|1,914|-|-| |||15,976|18,385|12,529|101,274| ## 12. PAYABLES: Amounts falling due within one year |Trade Payables
Social Security and other taxes
Other Payables
Accruals and Deferred Income|Group
Charity
2023
2022
2023
2022
£
£
£
£
4,945
2,443
2,247
1,720
6,111
896
5,390
-
1,383
1,127
257
-
6,147
25,540
6,147
25,540| |---|---| ||18,586
30,006
14,041
27,260| ______________________________________________________________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 26 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd (Charitable Company Limited by Guarantee) ## NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023 ## 13. ANALYSIS OF Funds |
or the Year Ended 31 October
3. ANALYSIS OF Funds|(onnue)
2023| |---|---| |GROUP
Opening balance
Net incoming/(outgoing)
resources
Transfer between funds
Closing Balance
CHARITY
Opening balance
Net incoming/(outgoing)
resources
Transfer between funds
Closing Balance|Unrestricted Funds
Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
250,000
762,428
189,287
1,201,715
1,284,787
-
-
(28,208)
80,608
52,400
(83,072)
-
-
-
-
-
-| ||-
250,000
734,220
269,895
1,254,115
1,201,715| ||Unrestricted Funds
Capital
Funds
Designated
Funds
General Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
250,000
709,066
189,287
1,148,353
1,229,214
-
-
(73,968)
80,608
6,640
(80,861)
-
-
-
-
-
-| ||-
250,000
635,098
269,895
1,154,993
1,148,353| ______________________________________________________________________________________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 27 DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0 ## Charis Cancer Care Ltd ## (Charitable Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023 ## 14. ANALYSIS OF NET ASSETS ||||Unrestricted Funds|||| |---|---|---|---|---|---|---| ||Capital|Designated|
General|Restricted|Total Funds|Total Funds| ||Funds|Funds|
Funds|Funds||| ||2023|2023|
2023|2023|2023|2022| ||£|£|
£|£|£|£| |Fixed Assets|-|-|
264,626|169,275|433,901|442,850| |Current Assets|-|250,000|
384,513|100,620|735,133|732,763| |Current Liabilities|-|-|(14,041)|-|(14,041)|(27,260)| |Net Assets|-|250,000|
635,098|269,895|1,154,993|1,148,353| ## 15. RELATED PARTY TRANSACTIONS The charity has availed of the exemption under FRS 102 in relation to the disclosure of transactions with group companies. ## 16. CONTINGENT LIABILITIES A contingent liability exists to repay grants received should certain conditions not be fulfilled by the charitable company. ______________________________________________________________________________________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 28